CAPTRUST Financial Advisors
MRNA icon

CAPTRUST Financial Advisors’s Moderna MRNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$541K Sell
10,654
-1,310
-11% -$61.1K ﹤0.01% 1984
2025
Q4 		$353K Buy
11,964
+1,044
+10% +$28.4K ﹤0.01% 2122
2025
Q3 		$282K Sell
10,920
-622
-5% -$17.4K ﹤0.01% 2209
2025
Q2 		$318K Buy
+11,542
New +$304K ﹤0.01% 2013
2024
Q4 		– Sell
-4,387
Closed -$293K – 2361
2024
Q3 		$293K Sell
4,387
-4,055
-48% -$372K ﹤0.01% 1889
2024
Q2 		$1M Sell
8,442
-40
-0.5% -$5.06K ﹤0.01% 1138
2024
Q1 		$904K Sell
8,482
-4,394
-34% -$443K ﹤0.01% 1183
2023
Q4 		$1.28M Sell
12,876
-99
-0.8% -$8.33K ﹤0.01% 1127
2023
Q3 		$1.34M Buy
12,975
+486
+4% +$54.2K 0.01% 1038
2023
Q2 		$1.52M Sell
12,489
-1,041
-8% -$139K 0.01% 953
2023
Q1 		$2.08M Sell
13,530
-4,401
-25% -$726K 0.01% 734
2022
Q4 		$3.22M Buy
17,931
+2,830
+19% +$463K 0.02% 565
2022
Q3 		$1.79M Buy
15,101
+4,158
+38% +$631K 0.01% 713
2022
Q2 		$1.56M Buy
10,943
+2,677
+32% +$383K 0.01% 673
2022
Q1 		$1.42M Sell
8,266
-427
-5% -$71.9K 0.01% 705
2021
Q4 		$2.21M Sell
8,693
-5,515
-39% -$1.61M 0.02% 540
2021
Q3 		$5.47M Buy
14,208
+837
+6% +$309K 0.05% 307
2021
Q2 		$3.14M Buy
13,371
+3,206
+32% +$573K 0.03% 384
2021
Q1 		$1.33M Buy
10,165
+1,168
+13% +$169K 0.01% 578
2020
Q4 		$940K Buy
8,997
+3,005
+50% +$304K 0.01% 626
2020
Q3 		$420K Sell
5,992
-11,344
-65% -$791K 0.01% 767
2020
Q2 		$1.07M Sell
17,336
-4,285
-20% -$235K 0.02% 485
2020
Q1 		$641K Sell
21,621
-272
-1% -$6.26K 0.01% 524
2019
Q4 		$421K Buy
+21,893
New +$388K 0.01% 738

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAPTRUST Financial Advisors's MRNA Position: Q1 2026 in Review

CAPTRUST Financial Advisors reduced its Moderna (MRNA) stake by 11% in Q1 2026, selling an estimated $61.1K and leaving 10,654 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

CAPTRUST Financial Advisors first reported a position in MRNA in Q4 2019 and has held it in 24 quarters since. The position peaked at $5.47M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • CAPTRUST Financial Advisors held 10,654 shares of Moderna worth $541K as of Q1 2026.
  • CAPTRUST Financial Advisors sold 1,310 Moderna shares in Q1 2026, an estimated $61.1K.
  • Moderna made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #1984 holding.
  • CAPTRUST Financial Advisors first reported a position in Moderna in Q4 2019 and has held it in 24 quarters since.
  • CAPTRUST Financial Advisors's Moderna position peaked at $5.47M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.